39 related articles for article (PubMed ID: 19308988)
1. Translational repression of mouse mu opioid receptor expression via leaky scanning.
Song KY; Hwang CK; Kim CS; Choi HS; Law PY; Wei LN; Loh HH
Nucleic Acids Res; 2007; 35(5):1501-13. PubMed ID: 17284463
[TBL] [Abstract][Full Text] [Related]
2. Evolutionarily conserved dual lysine motif determines the non-chaperone function of secreted Hsp90alpha in tumour progression.
Zou M; Bhatia A; Dong H; Jayaprakash P; Guo J; Sahu D; Hou Y; Tsen F; Tong C; O'Brien K; Situ AJ; Schmidt T; Chen M; Ying Q; Ulmer TS; Woodley DT; Li W
Oncogene; 2017 Apr; 36(15):2160-2171. PubMed ID: 27721406
[TBL] [Abstract][Full Text] [Related]
3. Regulation of CCAAT/enhancer-binding protein-beta isoform synthesis by alternative translational initiation at multiple AUG start sites.
Xiong W; Hsieh CC; Kurtz AJ; Rabek JP; Papaconstantinou J
Nucleic Acids Res; 2001 Jul; 29(14):3087-98. PubMed ID: 11452034
[TBL] [Abstract][Full Text] [Related]
4. Differential use of an in-frame translation initiation codon regulates human mu opioid receptor (OPRM1).
Song KY; Choi HS; Hwang CK; Kim CS; Law PY; Wei LN; Loh HH
Cell Mol Life Sci; 2009 Sep; 66(17):2933-42. PubMed ID: 19609488
[TBL] [Abstract][Full Text] [Related]
5. Structures of Hsp90α and Hsp90β bound to a purine-scaffold inhibitor reveal an exploitable residue for drug selectivity.
Huck JD; Que NLS; Sharma S; Taldone T; Chiosis G; Gewirth DT
Proteins; 2019 Oct; 87(10):869-877. PubMed ID: 31141217
[TBL] [Abstract][Full Text] [Related]
6. Structure-Based Design, Synthesis, and Biological Evaluation of Hsp90β-Selective Inhibitors.
Chaudhury S; Narasimharao Meka P; Banerjee M; Kent CN; Blagg BSJ
Chemistry; 2021 Oct; 27(59):14747-14764. PubMed ID: 34449940
[TBL] [Abstract][Full Text] [Related]
7. Translational regulation and protein-coding capacity of the 5' untranslated region of human TREM2.
Yanaizu M; Adachi H; Araki M; Kontani K; Kino Y
Commun Biol; 2023 Jun; 6(1):616. PubMed ID: 37291187
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Translational Efficiency by Disparate 5' UTRs of PPARgamma Splice Variants.
McClelland S; Shrivastava R; Medh JD
PPAR Res; 2009; 2009():193413. PubMed ID: 20016806
[TBL] [Abstract][Full Text] [Related]
9. Characterization and optimization of 5´ untranslated region containing poly-adenine tracts in Kluyveromyces marxianus using machine-learning model.
Zeng J; Song K; Wang J; Wen H; Zhou J; Ni T; Lu H; Yu Y
Microb Cell Fact; 2024 Jan; 23(1):7. PubMed ID: 38172836
[TBL] [Abstract][Full Text] [Related]
10. Control of eukaryotic protein synthesis by upstream open reading frames in the 5'-untranslated region of an mRNA.
Meijer HA; Thomas AA
Biochem J; 2002 Oct; 367(Pt 1):1-11. PubMed ID: 12117416
[TBL] [Abstract][Full Text] [Related]
11. Regulation of translation via mRNA structure in prokaryotes and eukaryotes.
Kozak M
Gene; 2005 Nov; 361():13-37. PubMed ID: 16213112
[TBL] [Abstract][Full Text] [Related]
12. Control mechanisms of differential translation of Hsp90 isoforms in 9L rat gliosarcoma cells.
Lo CW; Chang YS; Chao CC; Chang MD; Chang KC; Lai YK
J Cell Biochem; 2009 Jun; 107(3):418-27. PubMed ID: 19308988
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of Hsp90 isoforms in geldanamycin-treated 9L cells.
Chang YS; Lo CW; Sun FC; Chang MD; Lai YK
Biochem Biophys Res Commun; 2006 May; 344(1):37-44. PubMed ID: 16630568
[TBL] [Abstract][Full Text] [Related]
14. Concerted actions of multiple transcription elements confer differential transactivation of HSP90 isoforms in geldanamycin-treated 9L rat gliosarcoma cells.
Chao CC; Sun FC; Wang CH; Lo CW; Chang YS; Chang KC; Chang MD; Lai YK
J Cell Biochem; 2008 Jul; 104(4):1286-96. PubMed ID: 18320580
[TBL] [Abstract][Full Text] [Related]
15. Preferential translation mediated by Hsp81-3 5'-UTR during heat shock involves ribosome entry at the 5'-end rather than an internal site in Arabidopsis suspension cells.
Matsuura H; Shinmyo A; Kato K
J Biosci Bioeng; 2008 Jan; 105(1):39-47. PubMed ID: 18295718
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
